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In vivo microdialysis was used to estimate the extracellular concentrations of ceftazidime and ceftriaxone,
two expanded-spectrum cephalosporins commonly used in the treatment of bacterial meningitis, in two brain
regions (the right corpus striatum and the left lateral ventricle) of awake, freely moving rats. Antibiotics were
administered by constant intravenous infusion at 18 mg/h until steady-state levels were reached. Ceftriaxone
levels measured at the steady state in the extracellular space of the corpus striatum (0.80 6 0.17 mg/ml) were
statistically equivalent to those obtained in the cerebrospinal fluid of the lateral ventricle (0.71 6 0.15 mg/ml).
The ratios of these levels in the brain to the steady-state levels in plasma were 0.5 6 0.1% for both regions. The
postinfusion concentrations of ceftriaxone in the brain declined monoexponentially, with an elimination
half-life similar to that obtained in plasma. However, the mean antibiotic concentration of ceftazidime in the
striatum (2.2 6 0.4 mg/ml) was lower (P < 0.001) than that in the lateral ventricle (3.8 6 1.8 mg/ml), and the
ratios of concentrations in the striatum and ventricle to the concentration in plasma (2.4 6 0.5% and 4.0 6
1.8%, respectively) were higher than those obtained with ceftriaxone. Moreover, the half-life of ceftazidime
elimination from plasma was lower than that obtained in the two brain regions. It was concluded that the in
vivo microdialysis technique yields useful data on antibiotic distribution in the extracellular space of the brain,
that the distribution may not be homogeneous, and that the decay of postinfusion concentrations in the brain
may be different from the decay of postinfusion concentrations in plasma.
Treatment of bacterial cerebral infections requires the use
of bactericidal antibiotics that penetrate the cerebrospinal
fluid (CSF) and cerebral tissues. Although intracellular patho-
gens can cause meningitis, several microorganisms causing
central nervous system infections are located principally in the
extracellular space of the brain (8, 13). In these cases, mea-
surement of the antibiotic concentrations in the cerebral ex-
tracellular space (CES) may be more important than measure-
ment of total concentrations in brain tissues.
In vivo microdialysis sampling has commonly been used to
monitor the composition of the extracellular fluid in the central
nervous system. The recent application of this technique to
pharmacokinetic and metabolism studies has made it possible
to measure the free extracellular concentrations of drugs, as
well as their metabolites, in blood and tissues (14, 15). Before
the advent of the microdialysis technique, data on the distri-
bution of antibiotics and drugs in general into the CES of
experimental animals were scarce. Since its introduction, sev-
eral reports about the transport of drugs across the blood-brain
barrier and their distribution in different brain regions have
been published (16, 17, 19). A recent report described a study
in which microdialysis was used to investigate the distribution
of rifampin in the brains of anesthetized rats (9). However,
microdialysis has not been used to measure the penetration of
antibiotics into the brains of awake, freely moving animals.
In the present study, we used the in vivo microdialysis tech-
nique to investigate the penetration of ceftazidime (CFZ) and
ceftriaxone (CFX), two cephalosporin antibiotics commonly
used in the treatment of bacterial meningitis, into the brains of
awake, freely moving rats. We also analyzed the possible exis-
tence of regional differences in antibiotic concentrations by
measuring, simultaneously, the drug levels in two different
areas (the corpus striatum and the lateral ventricle) of the rat
brain.
MATERIALS AND METHODS
Drugs and animals.Vials of CFXmonohydrate were kindly supplied by Roche
Laboratories (Madrid, Spain). A commercially available preparation of CFZ
pentahydrate (Fortam; Glaxo Laboratories, Madrid, Spain) was used in the
experiments. Vials of CFX and CFZ were reconstituted with sterile water for
injection in accordance with the manufacturer’s recommendations, and subse-
quent dilutions were made with sterile normal saline. All of the other chemicals
used were of analytical or high-pressure liquid chromatography grade.
Male Wistar rats weighing 310 to 370 g were used throughout the study. Rats
had free access to food and water, and each rat was used only once.
Surgical procedures. Animals were anesthetized with chloral hydrate (400
mg/kg given intraperitoneally) and subjected to surgical cannulation of both
jugular veins with medical-grade silicone tubing (Silastic 602-135; Dow Corning
Co., Midland, Mich.) for perfusion of antibiotic solutions and collection of blood
samples at fixed times after drug administration. After that, rats were securely
positioned in a stereotaxic instrument (David Kopf Instruments) and two I-
shaped dialysis cannulae (12), localized in the right corpus striatum and the left
lateral ventricle, were implanted. The dialysis probes (inside diameter, 0.22 mm;
outside diameter, 0.31 mm) were prepared with polyacrylonitrile-sodium metha-
lylsulfonate copolymer (AN 69; Hospal, Bologna, Italy) capped with epoxy. The
exposed tip of the dialysis membrane was 4 mm long for the striatum cannula and
1 mm long for the cannula implanted in the lateral ventricle. The positions of the
Bregma and dura were used as reference points. The coordinates were 16 mm
A/P, 228 mm L/M, and 260 mm V/D for the striatum and 210 mm A/P, 114
mm L/M, and 235 mm V/D for the lateral ventricle, in accordance with the rat
stereotaxic atlas of Paxinos and Watson (11).
After surgery, the animals were put in individual cages with free access to food
and water for 18 to 24 h prior to the experiment.
When the experiment was terminated, each rat was given an overdose of
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chloral hydrate and the brain was fixed with 4% paraformaldehyde via intracar-
diac perfusion. Coronal sections (40 mm thick) were made to check the correct
placement of dialysis probes in accordance with the atlas of Paxinos and Watson
(11).
Drug administration. A solution of each antibiotic (36 mg/ml) was prepared in
normal saline, and each rat was infused with one of these solutions at a constant
flow rate of 0.5 ml/h through the left jugular vein cannula. Prior to the infusion,
an initial bolus of 0.5 ml of the antibiotic solution was administered.
Brain perfusions were started simultaneously with the intravenous infusion,
with Ringer solution at a constant flow rate of 1.25 ml/min (Perfusor Secura;
Braun, Melsungen, Germany). The Ringer solution contained 140 mM NaCl, 4.0
mM KCl, 1.2 mM CaCl2, and 1.0 mM MgCl2.
After steady-state levels of the antibiotic were reached (210 min of infusion),
brain dialysis samples were collected during three 30-min intervals (210 to 240,
240 to 270, and 270 to 300 min) and blood samples (0.3 ml) were withdrawn
through the right jugular vein cannula at the midpoint of each brain dialysis
collection period. Intravenous antibiotic infusion was stopped at 300 min. Dia-
lysates were collected during three additional 30-min intervals (315 to 345, 345 to
375, and 375 to 405 min), and three blood samples were collected at 315, 345, and
405 min.
Blood samples were centrifuged (1,000 3 g for 5 min), and plasma was stored
at 2208C until analysis.
Analytical techniques. CFX and CFZ concentrations in plasma and brain
dialysates were determined by high-pressure liquid chromatography with UV
detection. Brain dialysis samples (30 ml) were injected directly into the chro-
matographic system. Plasma samples (150 ml) were subjected to an extractive
procedure (6) prior to injection into the chromatograph. The mobile phase
consisted of 50 mM phosphate buffer (pH 6.5), 40 mM tetradecyltrimethylam-
monium bromide, acetonitrile, and methanol (45:15:30:10; vol/vol/vol/vol) for
CFX analysis and 100 nM acetate buffer (pH 3.5), 40 mM tetradecyltrimethyl-
ammonium bromide, and acetonitrile (78:2:20; vol/vol/vol) for CFZ analysis. The
mobile phase was always delivered at a flow rate of 1.0 ml/min with a Perkin
Elmer Series 4 delivery pump. Detection of antibiotics was performed at 270 nm
in a Hitachi 2000-S detector. The coefficient of variation of the analytical method
was less than 3%, the detection limit was about 0.05 mg/ml, and the assay was
linear up to 300 mg/ml (r . 0.99) for CFX. The respective values for CFZ were
3.7%, 0.1 mg/ml, and 250 mg/ml (r . 0.99).
Microdialysis probe characterization. To determine the extracellular concen-
trations in the striatum and the lateral ventricle, in vivo recovery was experimen-
tally estimated in awake rats. We used the extrapolation-to-zero flow rate
method described by Jacobson et al. (4) as follows. Six rats, cannulated and given
CFZ and CFX as described above, were used to estimate the recovery of each
antibiotic. After steady-state antibiotic levels in plasma and brain dialysates, the
rate of brain perfusion (Q) was changed and five different values (0.60, 1.25, 2.20,
4.40, and 9.00 ml/min) were used. The concentration of the antibiotic in the brain
dialysates (Cd) was determined at each brain perfusion rate. The dialysate
concentration-perfusion rate data were then fitted by means of a nonlinear
least-squares program (5) to the equation Cd 5 C(1 2 e2rA/Q), where C repre-
sents the actual concentration of the antibiotic in the brain extracellular medium,
r is the mass transport coefficient, and A represents the surface area of the
dialysis membrane. In vivo recoveries in the striatum and the lateral ventricle at
a perfusion rate of 1.25 ml/min were calculated by dividing the observed antibi-
otic concentrations in brain dialysates by the estimated concentrations in the
striatum and the lateral ventricle.
Pharmacokinetic methods and statistics. The elimination half-lives (t1/2) of
the antibiotics from plasma, the striatum, and the lateral ventricle were estimated
by fitting a monoexponential equation to the postinfusion plasma and brain
concentration-time data (5).
The extracellular concentrations of each antibiotic that were obtained at the
steady state in the striatum and the lateral ventricle were compared by means of
Student’s t test for paired data. A repeated-measures analysis of variance test,
followed by the Newman-Keuls multiple-comparison test, was used to compare
the t1/2 values for plasma and the two brain regions. A probability level of 0.05
was chosen for hypothesis testing.
RESULTS
In vivo recoveries varied for the different brain regions and
the antibiotic perfused. In our experimental conditions, recov-
ery in the lateral ventricle was 25% for CFZ and 51% for CFX,
whereas in the striatum recovery was 39% for CFZ and 73%
for CFX.
Figure 1 shows the plots of the CFZ concentrations versus
time in plasma, ventricular CSF, and the striatum (corrected
for the respective recoveries). Data obtained in the CFX ex-
periments are represented in Fig. 2. Table 1 summarizes the
mean steady-state levels and the t1/2 values. As can be seen, the
steady-state levels in brain regions and the ratio of these to the
steady-state levels in plasma were higher for CFZ than for
CFX.
The mean CFX concentration in the striatum was similar to
that found in the lateral ventricle. However, in the experiments
with CFZ a statistically significant difference between the two
brain regions was found. The mean CFZ concentration in the
striatum was only 58% of that in the lateral ventricle.
The postinfusion concentrations of CFX in the brain de-
clined monoexponentially, with elimination half-life values
similar to those in plasma (Fig. 2 and Table 1), suggesting rapid
equilibration between the brain compartments and plasma.
However, there were statistically significant differences be-
tween the t1/2 values obtained for CFZ in plasma and in the
brain regions studied. The t1/2 in plasma was 3.6 times lower
than in the striatum and 2 times lower than in the lateral
ventricle, which means that there are differences in the equil-
ibration kinetics of CFZ between plasma, the CES of the
striatum, and the CSF of the lateral ventricle.
FIG. 1. Mean levels and standard deviations of CFZ in plasma (F), the
extracellular space of the striatum (n), and the CSF of the lateral ventricle ()
after administration of a constant-rate intravenous infusion of 18 mg/h to rats.
FIG. 2. Mean levels and standard deviations of CFX in plasma (F), the
extracellular space of the striatum (n), and the CSF of the lateral ventricle ()
after administration of a constant-rate intravenous infusion of 18 mg/h to rats.
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DISCUSSION
Penetration of CFZ and CFX into the CSF through nonin-
flamed meninges has already been evaluated in humans by
several investigators. Both antibiotics show poor penetration of
the CSF, although they achieve bactericidal concentrations
against the commonest pathogens (1). The reported levels of
CFZ in CSF show a large interindividual variation. Fong and
Tomkins (3) reported CFZ concentrations in the CSF that
ranged from 0 to 1.8 mg/ml (mean, 0.66 mg/ml) 2 to 3 h after
administration of a 3-g intravenous dose. These levels repre-
sented 0.8% of the CFZ levels in serum. In another study (18),
CFZ concentrations in CSF were less than 1 mg/ml. Modai et
al. (10) reported CFZ concentrations of 5.4 and 23.5% in the
CSF 2 and 3 h, respectively, after an intravenous dose of 2 g
had been given to patients with meninges supposedly healed
after 11 to 20 days of treatment.
CFX penetration through noninflamed meninges seems to
be similar to that reported for other expanded-spectrum ceph-
alosporins, although this antibiotic exhibits a very high degree
of plasma protein binding (84 to 96% for concentrations in
plasma of 70 to 300 mg/ml) (1). After administration of a single
intravenous dose of 2 g of CFX, the mean penetration of the
CSF by the drug was approximately 1.5% (2).
The ratios of the concentration in CSF to the concentration
in plasma obtained in this study for CFZ and CFX (4.0 and
0.5%, respectively) are similar to those reported in humans,
which suggests that rats may be an adequate animal model for
studying the penetration of the brain by cephalosporin antibi-
otics.
No data have been previously published on the distribution
of CFZ or CFX in the extracellular space of the brain. CFX
levels measured in the extracellular space of the corpus stria-
tum were equivalent to those obtained in the CSF of the lateral
ventricle, and the t1/2 values for the two brain regions were
similar. These results show that with CFX, the two brain re-
gions are indistinguishable from a pharmacokinetic point of
view. However, with CFZ there were striking differences be-
tween the levels of this antibiotic measured in the lateral ven-
tricle and in the corpus striatum. As can be seen in Table 1, the
antibiotic concentration in the lateral ventricle was statistically
significantly higher than that obtained in the striatum. On the
other hand, the t1/2 values for CFZ varied with the compart-
ment studied. The t1/2 found in the striatum was somewhat
higher than that found in the lateral ventricle, and both were
higher than the value obtained in plasma (statistically signifi-
cant differences). All of these features indicate the existence of
kinetic differences between the compartments studied with
CFZ. Modai et al. (10) showed that the percent penetration of
CFZ into the CSF of patients determined 2 h after adminis-
tration was statistically significantly lower than that obtained
for samples collected 3 h after administration. No explanation
was given for these results. In our opinion, the differences
reported by these investigators could be explained by the fact
that the t1/2 values found in our study for the brain compart-
ments are higher than those obtained for plasma.
Antibiotic concentrations in the brains of humans and ani-
mals have usually been measured by CSF sampling via lumbar
puncture or by using a cannula implanted in the cisterna
magna. The use of concentrations in CSF is attractive, for it
has been demonstrated that, at least for certain drugs, CSF is
pharmacokinetically indistinguishable from other brain re-
gions. In fact, our findings on the penetration of the CES and
CSF of rats by CFX confirm this assumption. However, for
other drugs, the concentration in CSF is different from the
concentration in other brain regions. After intracerebroven-
tricular or even intravenous administration, processes like ef-
flux of the drug out of the ventricular compartment and trans-
port of the drug into the brain parenchyma may result in
spatial differences between drug concentrations. Wong et al.
(19) reported that the concentrations of zidovudine in thala-
mus extracellular fluid of rabbits were about half of those in
the CSF. Mandema et al. (7) showed that baclofen concentra-
tions in the CSF did not overlap the effect profile as measured
by electroencaphalographic recordings, indicating large differ-
ences in equilibration kinetics between plasma and the effect
site compared with the equilibration between plasma and CSF.
Mindermann et al. (9) also found unusually low concentrations
of rifampin in the extracellular space of the rat brain after
intraperitoneal administration of the antibiotic with the com-
pared total concentration in the CSF or brain, and they suggest
that the low rifampin levels attained in the CES could be
insufficient for treatment of some infections. Our findings on
CFZ distribution in the brains of rats, along with the above
reports, suggest that the use of CSF concentrations alone to
evaluate the penetration of the blood-brain barrier by antibi-
otics and, therefore, to check their efficiency in the treatment
of bacterial cerebral infections may not be enough. The use of
animals models can give important information about differ-
ences in the distribution of drugs in brain regions. In this sense,
the in vivo microdialysis technique is a useful tool for contin-
uous and simultaneous monitoring of the levels of drugs in
different regions of the brains of rats.
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